Atrial fibrillation: The beat is faster than the answers

Kidney International

Volumn 81, Issue 5, 2012, Pages 432-433

  Szczech, Lynda A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTITHROMBOCYTIC AGENT; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; RIVAROXABAN; WARFARIN;

BLEEDING; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION;

EID: 84857091918     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.430     Document Type: Note

References (15)

1. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 1 14: e 257-e 354.
2. Atar I, Konä D, Açikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106: 47-51. (Pubitemid 41728908)
3. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902. (Pubitemid 41505464)
4. Wizemann V, Tong L, Satayathum S et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. K idney Int 2010; 77: 1098-1106.
5. Vazquez E, Sanchez-Perales C, Garcia-Garcia F et al. Atrial fibrillation in incident dialysis patients. Kidney Int 2009; 76: 324-330.
6. United States Renal Data System. Annual Data Report, Researcher's Guide, Reference Tables, ADR Slides. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA; and US Renal Data System Coordinating Center. CD-ROMs, 2010.
7. Wetmore JB, Mahken JD, Rigler SK et al. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaideligible dialysis patients. K idney Int 2012; 81: 469-476.
8. Chan KE, Lazarus JM, Thadhani R et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009; 20: 2223-2233.
9. Granger CB, Alexander JH, McMurray JJV et al. Apixaban vs. warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
10. Patel MR, Mahaffey KW, Garg J et al. R ivaroxaban vs. warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
11. Wann LS, Curtis AB, January CT et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: 104-123.
12. Van Gelder IC, Groenveld HF, Crijns HJGM et al. Lenient vs. strict rate control in patients with atrial fibrillation. N Engl J Med 2010; 362: 1363-1373.
13. Talajic M, Khairy P, Levesque S et al. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010; 55 : 1796-1802.
14. Inrig JK, Oddone EZ, Hasselblad V et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. K idney Int 2007; 71: 454-461.
15. Wilber DJ, Pappone C, Neuzil P et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303: 333-340.